Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
Policy & Regulations + Font Resize -

CDSCO to have Central Drugs Testing Lab in Indore, plans offices in all states: Dr K Bengaru Rajan

Peethaambaran Kunnathoor, Indore
Saturday, October 31, 2015, 08:00 Hrs  [IST]

As part of its expansion plan, the Central Drugs Standard Control Organization (CDSCO) will set up a Central Drug Testing Laboratory (CDL) at Indore in Madhya Pradesh.

The land has been identified for the building in an ideal site and the construction work will be started soon, said Dr K Bengaru Rajan, deputy drugs controller, CDSCO, west zone.

He made this statement while addressing an assembly of pharma industry captains and professionals of pharmacy and pharma technology as guest of honour at the inaugural session of the IPA-MP Conclave and Pharma Tech Expo 2015 at the Brilliant Convention Centre in Indore on Friday.

The central regulatory agency will have offices in all the states in order to ensure strict regulations and to instill confidence among international regulators that all the drugs manufactured and exported from this country are properly checked and inspected. Currently, he said, CDSCO has six zonal offices and four sub-zonal offices. Besides, there are 12 offices in various ports.

For increasing the manpower, the central enforcement agency has now recruited 85 additional drug inspectors (ADIs). Fifty of them have joined and 35 are going to join immediately. Soon the organisation will have a total number of 155 drug inspectors to handle human resources functions, said Bengaru.

According to him, government of India does not want to compromise on the quality aspects of the drugs being produced in the country. For this, all the companies should comply with the good manufacturing practices (GMP) and latest technologies need to be updated. For this, government of India is going to amend the Schedule M provision of the D&C Act. The amendment process is in the pipeline. The draft of the amendment has already been circulated to the industry for their feedback.

In the 12th five year plan period, government of India has allotted Rs.1,700 crore for the expansion of regulatory mechanisms of central and state governments. Out of this, Rs.900 crore have been set apart for the expansion purpose of the central regulatory agency. Targeting this, the CDSCO wants to establish offices in all the states, he told Pharmabiz on the sidelines of the meeting.

The IPA-MP Conclave and the Expo was inaugurated by the media proprietor, Ramesh Chandra Agarwal, chairman of the Dainik Bhaskar group. He said government of India should strive for bringing up Indian pharma industry into the number one position in the world.

While welcoming the audience, the chairman of the organising committee, Dr S B, Rijhwani said the IPA-MP conclave will open new vistas for interactions between industry and academia, and also by suppliers and buyers of pharmaceutical machineries and equipments. The expo will exhibit mostly the Indian made machineries of latest technologies.

Dr V S V Vadlamudi, president of the Indian Pharmaceutical Association, presided over the meeting. He said the five divisions of the 77 years old IPA have participation in the IPA-MP conclave. IPA is giving prominence to the quality aspects of the formulations. All the Indian companies need to comply with the norms of regulations and manufacturers should follow the requirements of the regulatory bodies, not only from India, but also from outside, because India is exporting drugs to regulated markets, semi-regulated markets and to the rest of the world.

The biggest pharma industry conclave and technology expo of central India was organised by the Madhya Pradesh state branch of Indian Pharmaceutical Association (IPA) supported by Pharmatechnology Index, Ahmedabad.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |